Last mentioned: Mar 12, 2026
Phase 1 Implementation
Initial rollout of the AI-powered study build engine to sponsors and CROs.
Implementation Phase
Early adoption by sponsors and CROs to automate protocol-to-EDC translation.
Platform Launch
Scott Weidley introduces the AI-powered clinical trial build platform and Intelligent Trial Architecture.
Platform Launch
ClinCapture CEO Scott Weidley introduces the AI-powered study build engine.
Roadmap Expansion
Expansion of intelligent architecture to downstream trial workflows and predictive modeling.
ClinCapture CEO Scott Weidley has announced the integration of AI directly into the Captivate platform's architecture to automate the clinical trial build process. By converting static protocol documents into computable digital models, the new engine aims to significantly reduce manual configuration time and operational risk in life sciences research.
ClinCapture has launched an AI-powered clinical trial build platform that embeds artificial intelligence directly into its Captivate EDC architecture. The system automates the transition from clinical protocols to digital trial environments, aiming to eliminate manual configuration errors and accelerate study launch timelines.
ClinCapture has launched a foundational AI integration within its Captivate platform designed to automate the transition from clinical protocols to digital trial environments. By embedding AI into the trial's structural architecture, the company aims to eliminate manual configuration errors and significantly accelerate study launch timelines.
ClinCapture CEO Scott Weidley has unveiled a new AI-powered clinical trial build engine integrated into the Captivate platform. The system automates the translation of protocol specifications into digital EDC components, aiming to replace manual configuration with intelligent trial architecture.